Latest Breaking News On - Histopathology after efruxifermin treatment - Page 1 : comparemela.com

Akero Therapeutics Presents Analyses of Phase 2b HARMONY Study at the 2023 International Liver Congress Reinforcing and Characterizing EFX-Related Improvements in Liver Histopathology

Akero Therapeutics Presents Analyses of Phase 2b HARMONY Study at the 2023 International Liver Congress Reinforcing and Characterizing EFX-Related Improvements in Liver Histopathology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSarah oconnellChristina tartagliaTim rolphReshma shringarpureInternational liver congressAkero therapeutics incExchange commissionLiver congressTop posterHistopathology after efruxifermin treatmentAkero therapeuticsakero therapeuticsSouth sanLooking statementsPrivate securities litigation reform actAnnual report

Akero Therapeutics Presents Analyses of Phase 2b HARMONY Study at the 2023 International Liver

SOUTH SAN FRANCISCO, Calif., June 23, 2023 (GLOBE NEWSWIRE) Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high

United statesTim rolphReshma shringarpureSarah oconnellChristina tartagliaExchange commissionInternational liver congressAkero therapeutics incLiver congressTop posterHistopathology after efruxifermin treatmentSouth sanPrivate securities litigation reform actAnnual reportQuarterly report